NOPHO meeting

Nova Laboratories will be attending the NOPHO meeting in Norway, 10-13 May 14, as part of Nova’s continued commitment to support treatment of children with acute lymphoblastic leukemia (ALL) through our licensed product, Xaluprine™, (Mercaptopurine oral suspension).


Download all our latest product lists, this months Newsletter and news articles from Nova Laboratories.


Career Opportunities

We welcome speculative enquiries and applications from anyone with experience in the pharmaceutical industry, the right attitude and relevant qualifications.

Know More

Contact Us

For all product enquires, please contact our customer services team on 0800 975 48 40 or alternatively you can email us at [email protected]